2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Pyelitis: new trials by email Literature Review of Pyelitis trials Research Report on Pyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Study in the Emergency care management arm N°1 vs arm N°2, Care management - Pyelonephritis | Phase 2 | Terminated | Assistance Publique - Hôpitaux de Paris | 23 | 2012-05-01 | 2013-10-08 |
| GSK2251052 in Complicated Urinary Tract Infection GSK2251052, imipenem-cilastatin, Placebo - Infections, Urinary Tract | Phase 2 | Terminated | GlaxoSmithKline | 20 | 2011-06-28 | 2017-09-08 |
Pyelonephritis (2) · Infections (1) · Urinary Tract Infections (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Nephritis, Interstitial (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Infections (1)
3-(aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (1) · Cilastatin, Imipenem Drug Combination (1)
Assistance Publique - Hôpitaux de Paris (1) · GlaxoSmithKline (1)
France (2) · Canada (1) · Greece (1) · Russia (1) · Spain (1) · United States (1)